- B2Gold released its Q4 and FY2020 results this week, reporting strong growth in revenue and annual earnings per share with a significant beat on operational guidance.
- This continued outperformance has allowed the company to maintain its industry-leading dividend yield of 3.3%, with the next major catalyst being the Gramalote Feasibility Study due in Q2.
- However, while Gramalote offers upside looking out to FY2024, B2Gold is heavily reliant on the gold price for earnings growth in FY2021 and FY2022.
- Therefore, while I see this current correction as a low-risk buying opportunity, I am significantly underweight, because I believe there are more attractive opportunities elsewhere in the sector.
For further details see:
B2Gold: A Softer Year Ahead For Fekola